[go: up one dir, main page]

AU2001233543A1 - Carrier particles for drug delivery and process for preparation - Google Patents

Carrier particles for drug delivery and process for preparation

Info

Publication number
AU2001233543A1
AU2001233543A1 AU2001233543A AU3354301A AU2001233543A1 AU 2001233543 A1 AU2001233543 A1 AU 2001233543A1 AU 2001233543 A AU2001233543 A AU 2001233543A AU 3354301 A AU3354301 A AU 3354301A AU 2001233543 A1 AU2001233543 A1 AU 2001233543A1
Authority
AU
Australia
Prior art keywords
preparation
drug delivery
carrier particles
particles
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233543A
Inventor
Daniel L. Sparks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Ottawa
Original Assignee
University of Ottawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Ottawa filed Critical University of Ottawa
Publication of AU2001233543A1 publication Critical patent/AU2001233543A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1275—Lipoproteins or protein-free species thereof, e.g. chylomicrons; Artificial high-density lipoproteins [HDL], low-density lipoproteins [LDL] or very-low-density lipoproteins [VLDL]; Precursors thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001233543A 2000-02-14 2001-02-14 Carrier particles for drug delivery and process for preparation Abandoned AU2001233543A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09503187 2000-02-14
US09/503,187 US6514523B1 (en) 2000-02-14 2000-02-14 Carrier particles for drug delivery and process for preparation
PCT/CA2001/000175 WO2001058492A2 (en) 2000-02-14 2001-02-14 Carrier particles for drug delivery and process for preparation

Publications (1)

Publication Number Publication Date
AU2001233543A1 true AU2001233543A1 (en) 2001-08-20

Family

ID=24001073

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001233543A Abandoned AU2001233543A1 (en) 2000-02-14 2001-02-14 Carrier particles for drug delivery and process for preparation

Country Status (5)

Country Link
US (1) US6514523B1 (en)
EP (1) EP1257294A2 (en)
AU (1) AU2001233543A1 (en)
CA (1) CA2437289A1 (en)
WO (1) WO2001058492A2 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8568766B2 (en) * 2000-08-24 2013-10-29 Gattadahalli M. Anantharamaiah Peptides and peptide mimetics to treat pathologies associated with eye disease
US7592008B2 (en) * 2000-11-20 2009-09-22 The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois Membrane scaffold proteins
CA2486127C (en) 2002-05-17 2014-03-11 Esperion Therapeutics, Inc. Method of treating dyslipidemic disorders
WO2004010939A2 (en) * 2002-07-30 2004-02-05 Esperion Therapeutics, Inc. Methods of using non-human animal apoliprotein a-i protein
EP3254673A1 (en) * 2002-11-13 2017-12-13 The UAB Research Foundation Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use
JP4777873B2 (en) * 2003-02-14 2011-09-21 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド Lipophilic drug delivery vehicles and methods of use thereof
WO2004078991A2 (en) 2003-03-04 2004-09-16 Yeda Research And Development Co. Ltd. Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same
US20040253293A1 (en) * 2003-06-16 2004-12-16 Afshin Shafiee Rate controlled release of a pharmaceutical agent in a biodegradable device
AU2004283078A1 (en) * 2003-10-01 2005-05-06 Children's Hospital & Research Center At Oakland Lipophilic drug delivery vehicle and methods of use thereof
US7348802B2 (en) * 2004-06-15 2008-03-25 Stmicroelectronics Pvt. Ltd. Differential receiver
US20060134174A1 (en) * 2004-12-22 2006-06-22 Bausch & Lomb Incorporated Pharmaceutical delivery system and method of use
US20060165641A1 (en) * 2005-01-18 2006-07-27 Kumar Pillai Cosmetic compositions containing combinations of hydroxamate derivatives and antioxidants in a liposomal delivery system
US8206750B2 (en) 2005-03-24 2012-06-26 Cerenis Therapeutics Holding S.A. Charged lipoprotein complexes and their uses
US8932829B2 (en) * 2005-07-07 2015-01-13 Elena Dudich Recombinant alpha-fetoprotein and compositions thereof
US20090110739A1 (en) * 2007-05-15 2009-04-30 University Of North Texas Health Science Center At Forth Worth Targeted cancer chemotherapy using synthetic nanoparticles
CA2697957A1 (en) 2007-08-28 2009-03-12 Uab Research Foundation Synthetic apolipoprotein e mimicking polypeptides and methods of use
CA2704729C (en) * 2007-08-28 2020-06-23 Uab Research Foundation Synthetic apolipoprotein e mimicking polypeptides and methods of use
US8268796B2 (en) 2008-06-27 2012-09-18 Children's Hospital & Research Center At Oakland Lipophilic nucleic acid delivery vehicle and methods of use thereof
US8734853B2 (en) 2008-11-17 2014-05-27 University Of North Texas Health Science Center At Fort Worth HDL particles for delivery of nucleic acids
WO2011044545A2 (en) 2009-10-09 2011-04-14 Sigalov Alexander B Methods and compositions for targeted imaging
US12419839B2 (en) 2009-10-09 2025-09-23 Signablok, Inc. Methods and compositions for targeted delivery of protein fragments
KR101132626B1 (en) 2009-10-12 2012-04-02 주식회사 녹십자 Method for preparing HDL nanoparticles for the delivery of hydrophobic drugs
CA2830664A1 (en) * 2011-03-25 2012-10-04 The Trustees Of Columbia University In The City Of New York Pegylated human hdl particle and process for production thereof
CN102178954B (en) * 2011-04-25 2014-05-28 中国药科大学 Recombinant high density lipoprotein (HDL) medicament delivery system with functions of targeted and reverse cholesterol transport (RCT) on vascular wall and application thereof
CN102846551A (en) * 2011-06-28 2013-01-02 复旦大学 Liver-targeting high-density lipoprotein analogue nano-particles, preparation method thereof, and application thereof
CN102614515A (en) * 2012-04-16 2012-08-01 中国药科大学 Novel chemical restructuring high-density lipoprotein drug carrying system with targeted and double anti-tumor effects and application
BR112017001860A2 (en) 2014-07-31 2018-02-27 Uab Research Foundation synthetic peptide, pharmaceutical composition, methods, dosage regimen, and monoclonal antibody
WO2016154542A2 (en) * 2015-03-25 2016-09-29 The Regents Of The University Of Michigan Compositions and methods for treating cardiovascular related disorders
US20160346221A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
WO2018195382A1 (en) * 2017-04-21 2018-10-25 University Of North Texas Health Science Center Enhanced therapeutic agent and nucleic acid delivery via hdl or reconstituted hdl nanoparticles
CN115845752A (en) * 2022-11-24 2023-03-28 江南大学 Device and method for continuously preparing core-shell structure composite nanoparticles

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3319861C2 (en) 1983-06-01 1986-11-20 Arthur Pfeiffer Vakuumtechnik Wetzlar Gmbh, 6334 Asslar Gas flow meter
SE456136B (en) 1985-06-17 1988-09-12 Oncholab Ab PROCEDURE FOR THE PREPARATION OF A LIPOPHILIC BIOLOGY ACTIVE SUBSTANCE BASED BEARING BASIS OF RECONSTITUTED LDL (Layer Density Lipoprotein)
US5128318A (en) 1987-05-20 1992-07-07 The Rogosin Institute Reconstituted HDL particles and uses thereof
FR2664500B1 (en) 1990-07-13 1994-10-28 Lille Ii Universite Droit Sant PROCESS FOR THE PREPARATION OF A MODIFIED LIPOPROTEIN BY INCORPORATION OF AN ACTIVE LIPOPHILIC SUBSTANCE, MODIFIED LIPOPROTEIN THUS OBTAINED AND PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING THE SAME.
US5149801A (en) 1990-11-21 1992-09-22 The Regents Of The University Of California Boronated porphyrin compounds
US5576016A (en) 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5652339A (en) * 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins
US5795587A (en) 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
SE9702776D0 (en) * 1997-07-22 1997-07-22 Pharmacia & Upjohn Ab Method of preparing pharmaceutical compositions
US6287590B1 (en) 1997-10-02 2001-09-11 Esperion Therapeutics, Inc. Peptide/lipid complex formation by co-lyophilization

Also Published As

Publication number Publication date
CA2437289A1 (en) 2001-08-16
WO2001058492A2 (en) 2001-08-16
EP1257294A2 (en) 2002-11-20
US6514523B1 (en) 2003-02-04
WO2001058492A3 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
AU2001233543A1 (en) Carrier particles for drug delivery and process for preparation
AU2001235009A1 (en) Drug delivery apparatus
AU5711501A (en) Improved water-insoluble drug particle process
AU3403201A (en) Drug delivery device and method
HUP0101512A3 (en) Adhesive microsphere drug delivery composition, process for its preparation and device containing it
AU2123200A (en) Drug delivery device
AU4985600A (en) Drug delivery device
AU2002234184A1 (en) Packaging and delivery system for bone graft particles
AU3287699A (en) Ultrasound-mediated drug delivery
AU2002341959A1 (en) Drug delivery devices and methods
AU5914999A (en) Controlled release drug delivery
AU1719800A (en) Drug delivery systems and methods
IL138990A0 (en) Matrices for drug delivery and methods for making and using the same
HUP0203386A3 (en) Magnetic glass particles, method for their preparation and uses thereof
AU2002326494A1 (en) Products and drug delivery vehicles
AU2002211018A1 (en) Cellulosic particle for pharmaceutical preparation
HUP0104687A3 (en) Methods for preparing coated drug particles and pharmaceutical formulations thereof
AU4947100A (en) Drug delivery device
AU2001250027A1 (en) Apparatus for transport and delivery of articles
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
AU2001238346A1 (en) Modification of biopolymers for improved drug delivery
AU2001278622A1 (en) Amorphous carrier materials for drug delivery
AU2001276831A1 (en) Delivery vehicle composition and methods for delivering antigens and other drugs
AU2001270963A1 (en) Transdermal drug delivery system
AU4312101A (en) Secure delivery receptacle and method for using the same